KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) EBT (2016 - 2026)

Historic EBT for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to $252.7 million.

  • Exelixis' EBT rose 3675.59% to $252.7 million in Q1 2026 from the same period last year, while for Jan 2026 it was $941.2 million, marking a year-over-year increase of 3807.96%. This contributed to the annual value of $941.2 million for FY2026, which is 3807.96% up from last year.
  • As of Q1 2026, Exelixis' EBT stood at $252.7 million, which was up 3675.59% from $252.4 million recorded in Q4 2025.
  • Over the past 5 years, Exelixis' EBT peaked at $292.8 million during Q2 2024, and registered a low of -$31.4 million during Q4 2022.
  • In the last 5 years, Exelixis' EBT had a median value of $101.7 million in 2023 and averaged $132.2 million.
  • Data for Exelixis' EBT shows a peak YoY increase of 432972.7% (in 2022) and a maximum YoY decrease of 12662.83% (in 2022) over the last 5 years.
  • Exelixis' EBT (Quarter) stood at -$31.4 million in 2022, then soared by 427.87% to $103.0 million in 2023, then skyrocketed by 50.19% to $154.8 million in 2024, then soared by 63.1% to $252.4 million in 2025, then increased by 0.11% to $252.7 million in 2026.
  • Its last three reported values are $252.7 million in Q1 2026, $252.4 million for Q4 2025, and $230.4 million during Q3 2025.